Formula Growth Ltd. Purchases New Position in UnitedHealth Group Incorporated $UNH

Formula Growth Ltd. acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,827 shares of the healthcare conglomerate’s stock, valued at approximately $1,506,000.

Other institutional investors also recently bought and sold shares of the company. Tlwm lifted its holdings in shares of UnitedHealth Group by 1.0% in the 1st quarter. Tlwm now owns 2,736 shares of the healthcare conglomerate’s stock worth $1,433,000 after acquiring an additional 28 shares during the last quarter. Forefront Analytics LLC boosted its holdings in UnitedHealth Group by 4.2% during the 1st quarter. Forefront Analytics LLC now owns 820 shares of the healthcare conglomerate’s stock valued at $430,000 after acquiring an additional 33 shares during the period. TFB Advisors LLC lifted its position in shares of UnitedHealth Group by 2.7% during the first quarter. TFB Advisors LLC now owns 1,272 shares of the healthcare conglomerate’s stock worth $666,000 after purchasing an additional 33 shares during the last quarter. Bank OZK increased its stake in UnitedHealth Group by 4.6% in the 1st quarter. Bank OZK now owns 766 shares of the healthcare conglomerate’s stock worth $401,000 after buying an additional 34 shares during the period. Finally, GK Wealth Management LLC boosted its position in UnitedHealth Group by 7.2% in the 1st quarter. GK Wealth Management LLC now owns 506 shares of the healthcare conglomerate’s stock valued at $265,000 after buying an additional 34 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $330.61 on Friday. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $606.36. The business’s fifty day simple moving average is $341.79 and its 200-day simple moving average is $315.89. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.71. The company has a market cap of $299.48 billion, a PE ratio of 17.26, a PEG ratio of 2.16 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. During the same period last year, the business posted $7.15 earnings per share. The firm’s revenue was up 12.2% compared to the same quarter last year. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. UnitedHealth Group’s payout ratio is currently 46.14%.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Sanford C. Bernstein boosted their price target on UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a report on Thursday, October 30th. Cantor Fitzgerald restated an “overweight” rating and set a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. UBS Group increased their target price on shares of UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a report on Wednesday, October 29th. Jefferies Financial Group increased their price objective on shares of UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a research note on Friday, October 17th. Finally, Zacks Research upgraded UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Seventeen investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $385.54.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.